R&D News | pharmaphorum

News

Researchers in the US have devised a new depot system that could provide months or even years of delivery from a single subcutaneous injection.

News

Novo Nordisk has moved to shore up its obesity pipeline with a $2bn licensing deal for a triple agonist developed by China's United Biotechnology.

News

After its lead wet AMD drug failed a phase 3 trial, Opthea may have to make massive repayments to investors that would threaten its viability.

News

Belgian start-up Augustine raises €78m ($85m) in first-round funding for HDAC6 inhibitors headed by a candidate for Charcot-Marie-Tooth disease.

News

DNA testing specialist 23andMe has filed for bankruptcy, prompting the resignation of co-founder and chief executive Anne Wojcicki.

News

PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.